Bob Hoffman is AAM Vice Chair and Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions.
He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical industry. Prior to launching Lupin’s generic business in the US, he held multiple managerial roles at companies such as Pliva Pharmaceuticals, Lek Pharmaceuticals, Takeda Pharmaceuticals, and Schein Pharmaceuticals.
Bob has a Bachelor’s of Arts degree in Business Administration, with a concentration in Management and Marketing from Augustana College.
